| First Author | Matsumoto Y | Year | 2022 |
| Journal | J Clin Invest | Volume | 132 |
| Issue | 7 | PubMed ID | 35362478 |
| Mgi Jnum | J:327264 | Mgi Id | MGI:7261110 |
| Doi | 10.1172/JCI140869 | Citation | Matsumoto Y, et al. (2022) Tankyrase represses autoinflammation through the attenuation of TLR2 signaling. J Clin Invest 132(7):e140869 |
| abstractText | Dysregulation of Toll-like receptor (TLR) signaling contributes to the pathogenesis of autoimmune diseases. Here, we provide genetic evidence that tankyrase, a member of the poly(ADP-ribose) polymerase (PARP) family, negatively regulates TLR2 signaling. We show that mice lacking tankyrase in myeloid cells developed severe systemic inflammation with high serum inflammatory cytokine levels. We provide mechanistic evidence that tankyrase deficiency resulted in tyrosine phosphorylation and activation of TLR2 and show that phosphorylation of tyrosine 647 within the TIR domain by SRC and SYK kinases was critical for TLR2 stabilization and signaling. Last, we show that the elevated cytokine production and inflammation observed in mice lacking tankyrase in myeloid cells were dependent on the adaptor protein 3BP2, which is required for SRC and SYK activation. These data demonstrate that tankyrase provides a checkpoint on the TLR-mediated innate immune response. |
